Magenta Lifecare Board of Directors

Get the latest insights into the leadership at Magenta Lifecare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Divyesh Vipinchandra Modi Managing Director
Ms. Nidhi Bansal Ind. Non-Executive Director
Mr. Nandish Shaileshbhai Jani Ind. Non-Executive Director
Mr. Vipinchandra Somalal Modi Non Exe.Non Ind.Director
Ms. Khyati Modi Non Exe.Non Ind.Director

Magenta Lifecare Share price

MAGENTA

13.1

0.00 (0.00%)
Last updated on 16 Dec, 2025 | 09:35 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

11.10

52 Week High

28.28

alert_iconThe current prices are delayed, login to your account for live prices

Magenta Lifecare FAQs

The board at Magenta Lifecare consists of experienced professionals, including Mr. Divyesh Vipinchandra Modi , Ms. Nidhi Bansal , and others, overseeing the company’s strategic and corporate governance.

Directors at Magenta Lifecare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Divyesh Vipinchandra Modi is the current chairman at Magenta Lifecare.

Executive directors at Magenta Lifecare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Magenta Lifecare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Magenta Lifecare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.